Oncology & Hematolgy: Concept to Commercialization (Chapter 3 of 6)

Adam Callahan describes Caidya’s end-to-end support for oncology drug development, from initial concept through commercialization. He explains how understanding patient needs, therapeutic conditions, study design considerations, and regulatory evidence requirements informs the development of new therapies. Caidya’s therapeutic and scientific experts work with sponsors at key inflection points throughout the development pathway, helping connect early strategy with clinical execution and later-stage planning. This integrated perspective allows the team to support a molecule across its development lifecycle while maintaining focus on the data regulators require and the needs of patients who may ultimately receive the therapy.